CME Group Inc. (CME)
CME Group: Awaiting Multiples To Come In For This Premium Player
CME Group remains a dominant, highly profitable exchange with robust growth, strong margins, and disciplined capital allocation. CME trades at 24x earnings after a recent pullback, making valuations more appealing, but third quarter results were lackluster with declining trading volumes. CME is expanding into crypto and prediction markets, launching new products and partnerships to drive future growth amid rising competition.
CME: Exchange Operator's Bullish Streak Should Continue As Market Data Segment Grows
For my 4th coverage of CME Group Inc., I'm actually upgrading it to a Strong Buy, even more confident than today's consensus. A key growth factor could be driven by CME's market data /subscription-driven segment, but also 24/7 crypto trading. The firm has impeccable profit margins in its peer group, a low D/E, investment-grade rating from Fitch, and proven dividend growth.
CME Group Q3 Earnings Surpass Estimates, Revenues Decline Y/Y
CME's third-quarter results reflect declining revenues due to lower clearing and transaction fees and other, as well as lower trading volumes.
CME Group Inc. (CME) Q3 2025 Earnings Call Transcript
CME Group Inc. (NASDAQ:CME ) Q3 2025 Earnings Call October 22, 2025 8:30 AM EDT Company Participants Adam Minick - Investor Contact Terrence Duffy - Chairman & CEO Lynne Fitzpatrick - President & CFO Tim McCourt - Senior MD & Global Head of Equities, FX and Alternative Products Julie Winkler - Senior MD & Chief Commercial Officer Derek Sammann - Senior MD & Global Head of Commodities Markets Suzanne Sprague - Senior MD, Group COO & Global Head of Clearing Sunil Cutinho - Chief Information Officer Michael Dennis - Senior Managing Director & Global Head of Fixed Income Conference Call Participants Daniel Fannon - Jefferies LLC, Research Division Patrick Moley - Piper Sandler & Co., Research Division Benjamin Budish - Barclays Bank PLC, Research Division Brian Bedell - Deutsche Bank AG, Research Division Kenneth Worthington - JPMorgan Chase & Co, Research Division Christopher Allen - Citigroup Inc., Research Division Michael Cyprys - Morgan Stanley, Research Division Kyle Voigt - Keefe, Bruyette, & Woods, Inc., Research Division Simon Alistair Clinch - Rothschild & Co Redburn, Research Division Craig Siegenthaler - BofA Securities, Research Division William Qi - RBC Capital Markets, Research Division Presentation Operator Welcome to the CME Group Third Quarter 2025 Earnings. [Operator Instructions] I would now like to turn the call over to Adam Minick.
Compared to Estimates, CME (CME) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group (CME) Beats Q3 Earnings and Revenue Estimates
CME Group (CME) came out with quarterly earnings of $2.68 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.68 per share a year ago.
Will Earnings Move CME Group Stock?
CME (NASDAQ:CME), the largest derivatives marketplace in the world, is preparing to announce its Q3 2025 earnings on Wednesday, October 22. The firm manages essential exchanges including the Chicago Mercantile Exchange and the Chicago Board of Trade, where investors and institutions engage in trading futures and options to protect against fluctuations in interest rates, commodities, and equity indexes.
CME sees record volume in futures as investment demand now drives the gold market
Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.
What's in the Cards for CME Group This Earnings Season?
CME's third-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and expanding data services.
What Analyst Projections for Key Metrics Reveal About CME (CME) Q3 Earnings
Besides Wall Street's top-and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
CME Group Trades Above 200-Day SMA: Time to Hold CME Stock?
Solid global presence, a compelling product portfolio, increased electronic trading and a focus on over-the-counter clearing services poise CME for growth.
CME Group: If You Own This Stock, Hold On To It
CME Group outperformed the S&P 500 over the past decade, driven by its dominant derivatives platform and resilient revenue growth. Revenue per share has grown steadily, and CME maintains industry-leading low leverage, supporting its financial stability and risk profile. Dividend growth is strong and consistent, with both regular and special payouts, though the high payout ratio warrants monitoring.
